首页> 美国卫生研究院文献>Case Reports in Gastroenterology >Collision Tumor Comprising Primary Malignant Lymphoma and Adenocarcinoma in the Ascending Colon
【2h】

Collision Tumor Comprising Primary Malignant Lymphoma and Adenocarcinoma in the Ascending Colon

机译:在上行结肠中包含原发性恶性淋巴瘤和腺癌的碰撞肿瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe the case of a 78-year-old man with collision tumor from the primary malignant lymphoma and adenocarcinoma in the ascending colon. He suffered anemia from sigmoid colon cancer, and colonoscopy revealed early-stage colorectal cancer with a diameter of 20 mm in the cecum, the biopsy specimen showed moderately differentiated adenocarcinoma. Contrast-enhanced computed tomography (CT) revealed bowel wall thickening with contrast enhancement at the cecum; however, no lymph node and organ metastases were found. As above, we performed laparoscopic ileocecal resection with D3 lymph node dissection. The postoperative course was uneventful, and he was discharged from the hospital on postoperative day 11. Histopathological findings were moderately differentiated adenocarcinoma which invaded the muscularis propria and serosa from the submucosa, while the adjacent serosa showed a highly diffuse proliferation of atypical cells with an irregular nuclear-to-cytoplasmic ratio. Besides, immunohistochemical staining findings were diffuse large B-cell lymphoma, and diffuse large B-cell lymphoma was coexistent with moderately differentiated adenocarcinoma. We treated the patient with cyclophosphamide, doxorubicin, vincristine, and prednisolone in combination with rituximab (R-CHOP therapy) during 3 months postoperatively. When the 8 courses had been completed, postoperative positron emission tomography-CT (PET-CT) confirmed complete response, and the disease control has been doing well. Malignant lymphoma of the colorectal region is relative rare, and the occurrence of synchronous lymphoma and adenocarcinoma of the colon is also rare. Furthermore, collision tumor by these different entities is very unusual. We presented here such a case. The accurate clinical determination of the dominant tumor and a close follow-up is required for proper treatment in these cases.
机译:我们描述了一个78岁男性的案件,来自升上的结肠中的原发性恶性淋巴瘤和腺癌的碰撞肿瘤。他患有Sigmoid结肠癌的贫血,并且结肠镜检查显示盲肠中直径为20mm的早期结直肠癌,活组织检查标本显示出中度分化的腺癌。对比度增强的计算机断层扫描(CT)揭示了盲肠脊髓增厚的肠壁增厚;但是,没有发现淋巴结和器官转移。如上所述,我们用D3淋巴结解剖进行了腹腔镜对齐切除。术后课程是不行的,他在术后第11天从医院出院。组织病理学发现是中度分化的腺癌,腺癌从粘膜下侵入脓肿,而相邻的血清酶显示出具有不规则的非典型细胞的高弥漫性细胞核对细胞质比。此外,免疫组织化学染色结果弥漫性大B细胞淋巴瘤,并且弥漫性大B细胞淋巴瘤与中等分化的腺癌共存。我们在术后3个月内将患有环磷酰胺,多柔比星,长春螯合物和泼尼松酮的患者与Rituximab(R-Chec疗法)的治疗。当8个课程已经完成时,术后正电子发射断层扫描-CT(PET-CT)确认完全反应,疾病控制一直很好。结直肠区域的恶性淋巴瘤是相对罕见的,并且同步淋巴瘤和结肠腺癌的发生也很少见。此外,这些不同实体的碰撞肿瘤是非常不寻常的。我们在这里提供了这样的案例。在这些情况下适当治疗需要准确的临床测定和密切的随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号